Dr Reddys Stock Alpha and Beta Analysis


USD 52.57  0.38  0.73%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Dr Reddys Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Dr Reddys over a specified time horizon. Remember, high Dr Reddys' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Additionally, take a look at Dr Reddys Backtesting, Dr Reddys Valuation, Dr Reddys Correlation, Dr Reddys Hype Analysis, Dr Reddys Volatility, Dr Reddys History and analyze Dr Reddys Performance.
Please note that although Dr Reddys alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Dr Reddys did 0.031771  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Dr Reddys Laboratories stock's relative risk over its benchmark. Dr Reddys Laboratories has a beta of 0.44  . Let's try to break down what Dr Reddys's beta means in this case. As returns on the market increase, Dr Reddys returns are expected to increase less than the market. However, during the bear market, the loss on holding Dr Reddys will be expected to be smaller as well.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Dr Reddys Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Dr Reddys market risk premium is the additional return an investor will receive from holding Dr Reddys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Dr Reddys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Dr Reddys' performance over market.
α0.031771   β0.44
90 days against DJI

Dr Reddys expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Dr Reddys' Buy-and-hold return. Our buy-and-hold chart shows how Dr Reddys performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Dr Reddys Market Price Analysis

Market price analysis indicators help investors to evaluate how Dr Reddys stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dr Reddys shares will generate the highest return on investment. By understating and applying Dr Reddys stock market price indicators, traders can identify Dr Reddys position entry and exit signals to maximize returns.

Dr Reddys Return and Market Media

The median price of Dr Reddys for the period between Fri, May 20, 2022 and Thu, Aug 18, 2022 is 54.27 with a coefficient of variation of 3.02. The daily time series for the period is distributed with a sample standard deviation of 1.62, arithmetic mean of 53.83, and mean deviation of 1.25. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
Amarin to Slash Jobs as Generic Rivals Dull U.S. Prospects o...06/06/2022
Stocks in focus HFCL, DR. Reddy Labs, Bajaj Auto, HDFC, Auro...06/10/2022
Wipro, Dr Reddys Labs, and other stocks in news today - Time...06/16/2022
Dr. Reddys Gets 72M In Generic Suboxone Settlement - Law36006/24/2022
Dr Reddys stock recovers after falling 1 percent on observat...07/08/2022
Global Carfilzomib API Market 2022 Key Players Dr. Reddys La...07/21/2022
Dr Reddys Lab launches Bortezomib for Injection in US market...07/27/2022
Pharma, financial counters top on traders chart - Economic T...08/01/2022
US Stocks surge on easing inflation concerns - Business Stan...08/12/2022

About Dr Reddys Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Dr Reddys or other stocks. Alpha measures the amount that position in Dr Reddys Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Dr Reddys Upcoming Company Events

As portrayed in its financial statements, the presentation of Dr Reddys' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dr Reddys' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Dr Reddys' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Dr Reddys. Please utilize our Beneish M Score to check the likelihood of Dr Reddys' management manipulating its earnings.
Upcoming Quarterly Report4th of February 2017
Next Financial Report11th of May 2017
Next Fiscal Quarter End31st of December 2016
Next Fiscal Year End11th of May 2017
Last Quarter Report30th of September 2016
Last Financial Announcement31st of December 2015

Build Portfolio with Dr Reddys

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, take a look at Dr Reddys Backtesting, Dr Reddys Valuation, Dr Reddys Correlation, Dr Reddys Hype Analysis, Dr Reddys Volatility, Dr Reddys History and analyze Dr Reddys Performance. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Dr Reddys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Dr Reddys technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Dr Reddys trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...